SBC Medical Group (NASDAQ:SBC) Stock Rating Upgraded by Wall Street Zen

by · The Markets Daily

SBC Medical Group (NASDAQ:SBC – Get Free Report) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued on Monday, Wall Street Zen reports.

Other analysts have also issued reports about the company. Weiss Ratings upgraded SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, September 22nd. BTIG Research restated a “buy” rating and issued a $8.00 target price on shares of SBC Medical Group in a research note on Thursday, August 13th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

Read Our Latest Report on SBC Medical Group

SBC Medical Group Price Performance

SBC opened at $5.33 on Monday. The company has a market capitalization of $548.19 million, a price-to-earnings ratio of 11.34, a PEG ratio of 2.40 and a beta of 0.56. The company has a quick ratio of 3.27, a current ratio of 3.31 and a debt-to-equity ratio of 0.09. The firm has a 50-day moving average price of $4.13 and a 200-day moving average price of $3.64. SBC Medical Group has a twelve month low of $2.78 and a twelve month high of $5.51.

SBC Medical Group (NASDAQ:SBC – Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The business had revenue of $49.19 million during the quarter, compared to the consensus estimate of $45.37 million. Equities analysts expect that SBC Medical Group will post 0.44 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Bank of America Corp DE purchased a new stake in shares of SBC Medical Group in the second quarter worth $35,000. Bank of New York Mellon Corp purchased a new position in SBC Medical Group during the first quarter worth about $43,000. Deutsche Bank AG bought a new position in SBC Medical Group in the 2nd quarter worth about $58,000. Williams & Novak LLC increased its stake in SBC Medical Group by 31.2% in the 2nd quarter. Williams & Novak LLC now owns 18,686 shares of the company’s stock worth $58,000 after acquiring an additional 4,449 shares during the last quarter. Finally, Two Sigma Securities LLC purchased a new stake in shares of SBC Medical Group in the 2nd quarter valued at about $66,000. 60.82% of the stock is currently owned by hedge funds and other institutional investors.

SBC Medical Group Company Profile

(Get Free Report)

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.

See Also